The potential of OT receptor to ameliorate D2 response on striatal astrocytes might then be relevant to a new therapeutic approach to PD, and OT-mediated facilitation of D2 receptor-mediated responses would contribute to the control of PD. Here, OXT is linked to Parkinson disease.